Escitalopram and Duloxetine in Major Depressive Disorder: A Pharmacoeconomic Comparison Using UK Cost Data

Author： Wade Alan G.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.26, Iss.11, 2008-01, pp. : 969-981

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Double-Blind Comparison of Escitalopram and Duloxetine in the Acute Treatment of Major Depressive Disorder

By Khan Arif  

Clinical Drug Investigation, Vol. 27, Iss. 7, 2007-01 ,pp. : 481-492

Adis International

Access to resources Recommend Favorite

Evaluation of the Cost Effectiveness of Escitalopram versus Venlafaxine XR in Major Depressive Disorder

By Fernandez José-Luis  

PharmacoEconomics, Vol. 23, Iss. 2, 2005-01 ,pp. : 155-167

Adis International

Access to resources Recommend Favorite

Escitalopram: In the Treatment of Major Depressive Disorder in Adolescent Patients

By Yang Lily P.H.   Scott Lesley J.  

Pediatric Drugs, Vol. 12, Iss. 3, 2010-06 ,pp. : 155-163

Adis International

Access to resources Recommend Favorite

Escitalopram for the treatment of major depressive disorder in youth

By Ahn Joon-Ho   Patkar Ashwin A  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 14, 2011-10 ,pp. : 2235-2244

Informa Healthcare

Access to resources Recommend Favorite

Spotlight on Escitalopram in the Management of Major Depressive Disorder

By Murdoch David   Keam Susan J.  

CNS Drugs, Vol. 20, Iss. 2, 2006-01 ,pp. : 167-170

Adis International

Access to resources Recommend Favorite